Monday, Dec 18, 2017
engineered enzymes for better healthcare
All reasonable measures have been taken to ensure the quality, reliability, and accuracy of the information on this website. However, please be aware that Enzolve Technologies Limited:
• may delete, add to, or amend information on this website without notice
• is not responsible for the content of other websites linked to, or from, this website and,
• makes no warranties or representations, expressed or implied, as to the accuracy of information contained at this site.

This website is intended to provide information only. If you are seeking advice on any matters relating to information on this website, you should - where appropriate - contact us directly with your specific query or seek advice from qualified professional people.

Each page on this website must be read in conjunction with this disclaimer and any other disclaimer that forms part of the page or website.

 

  Back to Home 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...